Most recently, Revel Pharmaceuticals raised $5.8M in its Early Stage VC (Feb 2022).
- ·Watch Revel Pharmaceuticals: the Monday email on marks, rounds and moves
Revel Pharmaceuticals round by round
3 roundsHow much has Revel Pharmaceuticals raised?
Revel Pharmaceuticals has raised $14.7 million in total; 3 of its rounds are on record, from 2019 on. The largest on record was an $800,000 seed round in Mar 2021; the most recent was a $5.8 million early-stage round in Feb 2022.
Revel Pharmaceuticals has filed 3 Form Ds with the SEC since 2020, most recently in Mar 2022 ($5.8 million sold to 3 investors).
Revel Pharmaceuticals investors
9 investors are on record for Revel Pharmaceuticals, including Gaingels, Formic Ventures, Starbloom Capital and Kizoo Technology Capital. The early-stage round in Feb 2022 drew 3 investors.
9 investors have backed Revel Pharmaceuticals.
Frequently asked about Revel Pharmaceuticals
- How much has Revel Pharmaceuticals raised?
- Revel Pharmaceuticals has raised $14.7M in total across 3 recorded funding rounds.
- When was Revel Pharmaceuticals's last funding round?
- Revel Pharmaceuticals's most recent recorded round was Early Stage VC in Feb 2022, raising $5.8M.